The combination therapy of salinomycin and gefitinib using poly(d,l-lactic-co-glycolic acid)-poly(ethylene glycol) nanoparticles for targeting both lung cancer stem cells and cancer cells

PURPOSE: Lung cancer (LC) is the leading cause of cancer death worldwide. Evidences suggest that both LC cancer stem cells (CSCs) and cancer cells are supposed to be eliminated to achieve superior treatment effect against LC. Salinomycin could eradiate CSCs in various types of cancers, and gefitinib...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yu, Zhang, Qi, Sun, Jing, Liu, Huijie, Li, Qingfeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5709995/
https://www.ncbi.nlm.nih.gov/pubmed/29225473
http://dx.doi.org/10.2147/OTT.S141083

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5709995/
https://www.ncbi.nlm.nih.gov/pubmed/29225473
http://dx.doi.org/10.2147/OTT.S141083

Ejemplares similares